US Bancorp
APLT

US Bancorp’s Applied Therapeutics APLT Stock Holding History

US Bancorp’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,091
Closed -$60.6K – 3967
2023
Q4 		$60.6K Hold
18,091
– – ﹤0.01% 2578
2023
Q3 		$45K Hold
18,091
– – ﹤0.01% 2499
2023
Q2 		$23.2K Hold
18,091
– – ﹤0.01% 2905
2023
Q1 		$14.7K Buy
+18,091
New +$17.8K ﹤0.01% 3136
2021
Q4 		– Sell
-103
Closed -$2K – 4084
2021
Q3 		$2K Buy
+103
New +$1.78K ﹤0.01% 3852

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

US Bancorp's APLT Position: Q1 2024 in Review

US Bancorp sold out of Applied Therapeutics (APLT) in Q1 2024, closing a stake of 18,091 shares — an estimated $60.6K sold.

US Bancorp first reported a position in APLT in Q3 2021 and held it in 5 quarters. The position peaked at $60.6K in Q4 2023. 89 funds tracked by Wall St. Rank hold APLT as of Q1 2024.

  • US Bancorp reported no remaining Applied Therapeutics position as of Q1 2024 after selling out during the quarter.
  • US Bancorp sold 18,091 Applied Therapeutics shares in Q1 2024, an estimated $60.6K.
  • US Bancorp first reported a position in Applied Therapeutics in Q3 2021 and held it in 5 quarters.
  • US Bancorp's Applied Therapeutics position peaked at $60.6K in Q4 2023.
  • 89 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2024.

Based on US Bancorp's 13F filing for Q1 2024, filed 8 May 2024.